drug · antibody
IXIFI
Marketedupdated 3mo agoby $PFE PFIZER INC🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5Antibody drug with a maximum clinical stage of Approval (across all indications), with 8 approved and 44 investigational indications.
targets
Tumor necrosis factor
all catalysts(4)
approval · 4
Dec 13, 2017
approval
$PFE26.87+0.30%
IXIFI (INFLIXIMAB-QBTX) — FDA approval
IXIFI
→
Jan 16, 2020
approval
$PFE26.87+0.30%
IXIFI (INFLIXIMAB-QBTX) — FDA approval
IXIFI
→
Dec 26, 2023
approval
$PFE26.87+0.30%
IXIFI (INFLIXIMAB-QBTX) — FDA approval
IXIFI
→
Oct 9, 2025
approval
$PFE26.87+0.30%
IXIFI (INFLIXIMAB-QBTX) — FDA approval
IXIFI
→
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 19m ago
Found something off?
comments(0)
5-min edit window · permanent after that